Fibra de sisal como envoltório na drenagem agrícola

O trabalho foi realizado objetivando analisar o desempenho do sistema de drenagem com fibra de sisal envolto orgânico como material alternativo.  A pesquisa foi realizada no Laboratório de Engenharia de Irrigação e Drenagem da Universidade Federal de Campina Grande. Usando-se um sistema experimental composto de nove tanques construídos de alvenaria e impermeabilizados internamente. Os tratamentos foram dispostos em um arranjo fatorial com três tipos de tubos, Drenoflex, Kananet e tubo de PVC liso próprio para Esgoto envolto com fibra de sisal num delineamento inteiramente casualizado com três repetições. Foram avaliados a carga hidráulica de entrada (he), fluxo(q) e resistência de entrada(re) e analisados  estatisticamente, utilizando-se o software ASSISTAT . A comparação dos tubos Drenoflex, PVC liso e Kananet envolto com fibra de sisal, as médias da carga hidráulica na entrada para os tubos variando os valores de 0,40486 a 0,35543, sendo significativo para o tubo Kananet, devido possuir furos maiores facilitando assim a passagem da água pelo tubo. E em relação à resistência de entrada na interação entre os tubos drenantes e a fibra de sisal diferiu estatisticamente com o tubo PVC liso. O desempenho do sistema drenante com envolto de fibra de sisal é considerado muito bom

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells

In approximately 15% of patients with acute myeloid leukemia (AML), total and phosphorylated EGFR proteins have been reported to be increased compared to healthy CD34(+) samples. However, it is unclear if this subset of patients would benefit from EGFR signaling pharmacological inhibition. Pre-clinical studies on AML cells provided evidence on the pro-differentiation benefits of EGFR inhibitors when combined with ATRA or ATO in vitro. Despite the success of ATRA and ATO in the treatment of patients with acute promyelocytic leukemia (APL), therapy-associated resistance is observed in 5-10% of the cases, pointing to a clear need for new therapeutic strategies for those patients. In this context, the functional role of EGFR tyrosine-kinase inhibitors has never been evaluated in APL. Here, we investigated the EGFR pathway in primary samples along with functional in vitro and in vivo studies using several APL models. We observed that total and phosphorylated EGFR (Tyr992) was expressed in 28% and 19% of blast cells from APL patients, respectively, but not in healthy CD34(+) samples. Interestingly, the expression of the EGF was lower in APL plasma samples than in healthy controls. The EGFR ligand AREG was detected in 29% of APL patients at diagnosis, but not in control samples. In vitro, treatment with the EGFR inhibitor gefitinib (ZD1839) reduced cell proliferation and survival of NB4 (ATRA-sensitive) and NB4-R2 (ATRA-resistant) cells. Moreover, the combination of gefitinib with ATRA and ATO promoted myeloid cell differentiation in ATRA- and ATO-resistant APL cells. In vivo, the combination of gefitinib and ATRA prolonged survival compared to gefitinib- or vehicle-treated leukemic mice in a syngeneic transplantation model, while the gain in survival did not reach statistical difference compared to treatment with ATRA alone. Our results suggest that gefitinib is a potential adjuvant agent that can mitigate ATRA and ATO resistance in APL cells. Therefore, our data indicate that repurposing FDA-approved tyrosine-kinase inhibitors could provide new perspectives into combination therapy to overcome drug resistance in APL patients

B-cell regeneration profile and minimal residual disease status in bone marrow of treated multiple myeloma patients

© 2021 by the authors.B-cell regeneration during therapy has been considered as a strong prognostic factor in multiple myeloma (MM). However, the effects of therapy and hemodilution in bone marrow (BM) B-cell recovery have not been systematically evaluated during follow-up. MM (n = 177) and adult (≥50y) healthy donor (HD; n = 14) BM samples were studied by next-generation flow (NGF) to simultaneously assess measurable residual disease (MRD) and residual normal B-cell populations. BM hemodilution was detected in 41 out of 177 (23%) patient samples, leading to lower total B-cell, B-cell precursor (BCP) and normal plasma cell (nPC) counts. Among MM BM, decreased percentages (vs. HD) of BCP, transitional/naïve B-cell (TBC/NBC) and nPC populations were observed at diagnosis. BM BCP increased after induction therapy, whereas TBC/NBC counts remained abnormally low. At day+100 postautologous stem cell transplantation, a greater increase in BCP with recovered TBC/NBC cell numbers but persistently low memory B-cell and nPC counts were found. At the end of therapy, complete response (CR) BM samples showed higher CD19− nPC counts vs. non-CR specimens. MRD positivity was associated with higher BCP and nPC percentages. Hemodilution showed a negative impact on BM B-cell distribution. Different BM B-cell regeneration profiles are present in MM at diagnosis and after therapy with no significant association with patient outcome.This work has been supported by the International Myeloma Foundation-Black Swan Research Initiative, the EuroFlow Consortium (grant LSHB-CT-2006-018708); Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC; Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Madrid, Spain and FONDOS FEDER), numbers: CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480; grant from Bilateral Cooperation Program between Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES (Brasília/Brazil) and Dirección General de Políticas Universitárias (DGPU)-Ministério de Educación, Cultura y Deportes (Madrid/Spain) number DGPU 311/15; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro of Brazil (FAPERJ) numbers: E26/110.105/2014 and E26/102.191/2013; grant from Conselho Nacional de Desenvolvimento Científico e Tecnológico of Brazil (CNPQ), number: 400194/2014-7. R.M.d.P. was supported by a grant from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/DGPU), number: 000281/2016-06 and CAPES/PROEX 641/2018, Brazil; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro of Brazil (FAPERJ) number: E01/200/537/2018

Structural conditions that leads to photoluminescence emission in SrTi'O IND.3': an experimental and theoretical approach

Complex cluster [ TiO5·VOz] and [ SrO11·VOz] (where VOz =VOX ,VO•, VO•• vacancies were identified in disordered SrTiO3 powders prepared by the polymeric precursor method, based on experimental measurements by x-ray absorption near edge structure spectroscopy. The paramagnetic complex states of [ TiO5·VO•] and [ SrO11·VO•] with unpaired electrons were confirmed by electron paramagnetic resonance spectroscopy. The disordered powders showed strong photoluminescence at room temperature. Structural defects of disordered powders, in terms of band diagram, density of states, and electronic charges, were interpreted using high-level quantum mechanical calculations in the density functional framework. The four periodic models used here were consistent with the experimental data and explained the presence of photoluminescence.FAPESP/CEPIDCNPq/PRONEXCAPE

Reconhecimento de Dígitos de Medidores de Energia por meio da Voz no Contexto de um Aplicativo de Autoleitura / Digit Recognition of Energy Meters through Voice in the Context of an Authentication Application

A Agência Nacional de Energia Elétrica (ANEEL) destaca que perdas não-técnicas estão relacionadas a entraves no processo de leitura de consumo. Para a redução dessas falhas, uma alternativa factível e de menor custo seria a leitura realizada pelo próprio consumidor, denominada de autoleitura.  Este processo leva em consideração o uso de plataformas digitais, através das quais o consumidor registraria e enviaria as informações de consumo.  Uma etapa importante desse processo é o reconhecimento automático de dígitos de medidores por meio da voz.  Este trabalho, portanto, propõe um método para a realização dessa tarefa, que utiliza processamento de áudio e inteligência computacional. Para a extração de características de áudio, utiliza-se Mel-frequency Cepstral Coefficients (MFCC) e MelSpectrogram de forma combinada. O método apresenta Recall de 94,74%; Precision de 94,91%; F1 score de 94,72% e 0,9419 de índice Kappa utilizando-se o classificador Support Vector Machine (SVM)